What are the clinically important drug‑drug interactions of sertraline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Clinically Important Drug-Drug Interactions of Sertraline

Sertraline has several critical drug-drug interactions that can lead to life-threatening complications, most notably serotonin syndrome when combined with MAOIs or other serotonergic agents, and increased bleeding risk when combined with NSAIDs or anticoagulants.

Contraindicated Combinations

Absolute contraindication exists for sertraline with MAOIs (phenelzine, isocarboxazid, moclobemide, isoniazid, linezolid, and intravenous methylene blue) due to risk of fatal serotonin syndrome 1, 2. Sertraline must be discontinued before initiating MAOI therapy, and adequate washout periods must be observed.

Pimozide is contraindicated with sertraline 2. Despite sertraline 200 mg daily increasing pimozide AUC and Cmax by approximately 40% at a 2 mg pimozide dose 2, 3, the narrow therapeutic index of pimozide makes this combination dangerous, even though no QT changes were observed in controlled studies 3.

High-Risk Serotonergic Combinations

Exercise extreme caution when combining sertraline with other serotonergic drugs 1, 2:

  • Other antidepressants (SSRIs, SNRIs, TCAs, atypical antidepressants)
  • Opioids: tramadol, meperidine, methadone, fentanyl (fentanyl-venlafaxine showed strong signals in FAERS data 4)
  • Triptans: weakness, hyperreflexia, and incoordination reported 2
  • Stimulants: amphetamines and possibly methylphenidate
  • OTC medications: dextromethorphan, chlorpheniramine, St. John's wort, L-tryptophan
  • Illicit drugs: MDMA, methamphetamine, cocaine, LSD

When combining non-MAOI serotonergic drugs is clinically necessary, start the second agent at low dose, increase slowly, and monitor intensively for serotonin syndrome symptoms in the first 24-48 hours after each dose change 1, 2.

Serotonin syndrome presents with mental status changes (confusion, agitation), neuromuscular hyperactivity (tremors, clonus, hyperreflexia, rigidity), and autonomic instability (hypertension, tachycardia, hyperthermia, diaphoresis). Advanced cases include fever, seizures, arrhythmias, and unconsciousness requiring immediate hospitalization and discontinuation of all serotonergic agents 1, 2.

Bleeding Risk Interactions

Sertraline significantly increases bleeding risk when combined with NSAIDs or anticoagulants 1. Recent FAERS analysis demonstrated that sertraline combined with NSAIDs may increase acute kidney injury risk (multiplicative model = 2.14) 5. Abnormal bleeding events include ecchymosis, hematoma, epistaxis, petechiae, and hemorrhage 1.

With warfarin, SSRIs including sertraline more than doubled bleeding risk compared to warfarin alone 6. While sertraline and citalopram/escitalopram are preferred over fluvoxamine and fluoxetine when SSRI therapy is required in anticoagulated patients 6, heightened vigilance remains essential.

CYP450-Mediated Interactions

Sertraline has moderate effects on CYP2D6 metabolism 1:

  • CYP2D6 substrates requiring dose reduction: TCAs, Type 1C antiarrhythmics (propafenone, flecainide)
  • Monitor closely: drugs with narrow therapeutic indices metabolized by CYP2D6

Sertraline does NOT significantly inhibit CYP3A4 2. Studies with terfenadine, carbamazepine, and cisapride showed no clinically significant CYP3A4 inhibition. Notably, sertraline actually reduced cisapride concentrations by 35% (likely through induction) 2, 3.

Specific Drug Interactions Requiring Monitoring

Lithium: Monitor plasma levels following sertraline initiation and adjust lithium dose accordingly 2.

Phenytoin: Monitor plasma concentrations after starting sertraline, particularly in patients with multiple comorbidities or on multiple medications 2. Case reports document elevated phenytoin levels with sertraline 7.

Valproate: Monitor plasma levels following sertraline initiation 2.

Lamotrigine: Sertraline can double lamotrigine levels even at low doses (25 mg daily), likely through glucuronidation inhibition 8. Monitor for toxicity symptoms and obtain serial blood levels.

QT Prolongation Considerations

While sertraline has lower QT prolongation risk compared to citalopram/escitalopram 9, caution is warranted when combining with other QT-prolonging drugs 1. The 2023 Canadian guidelines note sertraline has "negligible" QT risk, making it preferable to citalopram/escitalopram in at-risk patients 9.

Common Pitfalls

  • Relying on single DDI checker: 10.16% of documented sertraline interactions are not indexed in major databases 4
  • Overlooking "hidden" serotonergic agents: linezolid (antibiotic), fentanyl (opioid), methylene blue showed strong FAERS signals 4
  • Underestimating NSAID risk: Both prescription and OTC NSAIDs increase bleeding and potentially kidney injury risk 5
  • Inadequate washout periods: When switching between serotonergic agents, ensure appropriate drug-free intervals 2

References

1
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

6
Guideline

drug interactions affecting oral anticoagulant use.

Circulation: Arrhythmia and Electrophysiology, 2022

Related Questions

Does sertraline have anticholinergic activity?
What is the appropriate evaluation and management for a 25‑year‑old woman with a copper intrauterine device who recently discontinued sertraline and is now experiencing frequent spotting while the IUD remains in place?
Does Zoloft (sertraline) work for a dog that licks its paws?
Why was my patient’s sertraline stopped abruptly?
After increasing sertraline (Zoloft) from 25 mg to 50 mg, how long does it take to notice a difference?
When should opioids be used for pain management in acute pancreatitis, and what are the recommended dosing and monitoring guidelines?
Are there any renal or hepatic considerations when restarting sertraline after an abrupt discontinuation?
What are the appropriate dosing guidelines for sertraline in adults, including initiation, titration, maximum dose, and adjustments for hepatic impairment?
Can you list the essential information to include in a concise endocrine clerkship report for each patient (demographics, chief complaint, endocrine history, medications, comorbidities, vital signs, focused physical exam findings, laboratory results, imaging, acute complications, and management plan)?
What loading and maintenance doses of teicoplanin should be given to an adult with an estimated glomerular filtration rate of 17 mL/min/1.73 m²?
What is the interaction between apixaban and sertraline, and how should the bleeding risk be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.